Trade CELU stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Celularity Inc. Class A (CELU) is trading at US$1.18, down 4.84% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$23.16M. Over the past 52 weeks, CELU has traded between US$0.56 and US$2.55. On Syfe you can trade CELU with $0 commission and add it to your watchlist.
| Previous close | US$1.24 |
|---|---|
| Market cap | US$23.16M |
| 52-week range | US$0.56 – US$2.55 |
| Volume | 154.7K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Celularity Inc. Class A
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert Joseph Hariri Gordon in 2016 and is headquartered in Florham Park, NJ.
Year: 2021
Celularity Appoints Chief Operating Officer
Jun 26, 9:49 AM · MT Newswires
Celularity Regains Nasdaq Listing Compliance, Shares Rise
May 1, 8:53 PM · MT Newswires
Celularity Inc. Class A (CELU) stock is trading at US$1.18, -4.84% from the previous close of US$1.24.
The market cap for Celularity Inc. Class A (CELU) stock is approximately US$23.16M.
The 52-week high for Celularity Inc. Class A (CELU) stock is US$2.55.
The 52-week low for Celularity Inc. Class A (CELU) stock is US$0.56.
Celularity Inc. Class A (CELU) does not currently pay a dividend.
Stay on top of CELU
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore